Anagrelide and myelofibrosis Patient Reports February 11, 2012



Anagrelide Side Effects Report #5175224-9
Anagrelide side effect was reported by a Physician from CZECH REPUBLIC on Nov 23, 2006. Female patient was diagnosed with thrombocytopenia and was treated with Anagrelide. After drug was administered, patient experienced the following side effects: asthenia, dizziness What is  dizziness, megakaryocytes abnormal, myelofibrosis, sensation of pressure. Anagrelide dosage: 0.5MG DAILY, ORAL; SEE IMAGE. During the same period patient was treated with ANAGRELIDE HYDROCHLORIDE, HYDROXYUREA, ANOPYRIN. Patient recovered.

Anagrelide Side Effects Report #5715764-4
Anagrelide side effect was reported by a Physician from SWEDEN on Apr 08, 2008. Male patient, 68 years of age, was diagnosed with essential thrombocythaemia, myelofibrosis and was treated with Anagrelide. After drug was administered, patient experienced the following side effects: anaemia, myelofibrosis, platelet count increased, therapeutic response delayed, thrombocytopenia. Anagrelide dosage: 1.0 MG AM AND 2.0 MG EVENING, ORAL. During the same period patient was treated with PEGASYS. Patient recovered.

Anagrelide Side Effects Report #5180123-2
Anagrelide side effect was reported by a Health Professional from SPAIN on Dec 01, 2006. Female patient was diagnosed with essential thrombocythaemia and was treated with Anagrelide. After drug was administered, patient experienced the following side effects: myelofibrosis, myeloid metaplasia. Anagrelide dosage: unknown. Patient recovered.

Anagrelide Side Effects Report #5688192-8
Anagrelide side effect was reported by a Physician from SWEDEN on Mar 12, 2008. Male patient was diagnosed with essential thrombocythaemia, myelofibrosis and was treated with Anagrelide. After drug was administered, patient experienced the following side effects: myelofibrosis, platelet count decreased. Anagrelide dosage: 1.0 MG AM AND 2.0 MG EVENING, ORAL. During the same period patient was treated with PEGASYS. Patient recovered.


Anagrelide Side Effects Report #5786767-9
Anagrelide side effect was reported by a Physician from UNITED KINGDOM on June 13, 2008. Female patient, 78 years of age, was treated with Anagrelide. After drug was administered, patient experienced the following side effects: myelofibrosis. Anagrelide dosage: unknown. Patient recovered.

Anagrelide Side Effects Report #5114744-X
Anagrelide side effect was reported by a Physician from FRANCE on Sept 15, 2006. Male patient, 61 years of age, was treated with Anagrelide. After drug was administered, patient experienced the following side effects: leukocytosis, myelocytosis, myelofibrosis, neutrophil count increased, splenomegaly. Anagrelide dosage: 0.5 MG, 2 CAPSULES DAILY,. Patient recovered.

Anagrelide Side Effects Report #5786768-0
Anagrelide side effect was reported by a Physician from UNITED KINGDOM on June 13, 2008. Female patient, 40 years of age, was treated with Anagrelide. After drug was administered, patient experienced the following side effects: myelofibrosis. Anagrelide dosage: unknown. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Anagrelide